Replies to post #107818 on Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

RGBP I’m in It To Win It!
Great Job Dr. KOO’s
https://docoh.com/news/benzinga/26172220/regen-biopharma-inc?fromCompany=1589150
During the quarter ended June 30, 2021 the Company was paid $1,905,000 in cash and securities resulting from two licenses granted in April, 2021 to Oncology Pharma, Inc. ("ONPH").
Pursuant to the terms and conditions of the licenses granted ONPH became obligated to:
(a) Pay nonrefundable fees of $55,000 and fifty thousand common shares of ONPH no later than April 20, 2021
(b) Pay royalties equal to five percent (5%) of the Net Sales (as Net Sales are defined in the Agreement) of any Licensed Products in a quarter.

[pumper_stumper]

as the filings pointed out, this "great progress" came about after a default on this "small debt that can easily be paid with cash" that wasnt. instead it was paid via dilution. i look forward to more "great progress", aka dilution.